CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan-cancer multi-omics and functional studies
Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality, and mitochondrial proteins have been increasingly implicated in tumor progression. Coiled-coil-helix-coiled-coil-helix domain-containing 2 (CHCHD2) has been reported in several malignancies, yet its pan-cancer landscape and LUAD-specific fu...